EA201590049A1 - Композиции и способы для лечения участков отсутствующей костной ткани и открытых переломов - Google Patents

Композиции и способы для лечения участков отсутствующей костной ткани и открытых переломов

Info

Publication number
EA201590049A1
EA201590049A1 EA201590049A EA201590049A EA201590049A1 EA 201590049 A1 EA201590049 A1 EA 201590049A1 EA 201590049 A EA201590049 A EA 201590049A EA 201590049 A EA201590049 A EA 201590049A EA 201590049 A1 EA201590049 A1 EA 201590049A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
compositions
bornt
open
bone tissue
Prior art date
Application number
EA201590049A
Other languages
English (en)
Other versions
EA027543B1 (ru
Inventor
Ноам Эмануэль
Original Assignee
Полипид Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Полипид Лтд. filed Critical Полипид Лтд.
Publication of EA201590049A1 publication Critical patent/EA201590049A1/ru
Publication of EA027543B1 publication Critical patent/EA027543B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/28—Bones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/12—Phosphorus-containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3608—Bone, e.g. demineralised bone matrix [DBM], bone powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/22—Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polymers & Plastics (AREA)

Abstract

Изобретение относится к композициям, способам и медицинским изделиям для лечения отсутствующих участков кости и дефектов кости. Способы согласно настоящему изобретению включают этап введения в участок костной полости или дефекта кости композиции, содержащей матрицу, которая обеспечивает местное пролонгированное высвобождение по меньшей мере одного антибиотика в указанном участке отсутствующей костной ткани.
EA201590049A 2012-08-02 2013-08-01 Композиции и способы для лечения участков отсутствующей костной ткани и открытых переломов EA027543B1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261678655P 2012-08-02 2012-08-02
US201261739792P 2012-12-20 2012-12-20
US201361778791P 2013-03-13 2013-03-13
PCT/IL2013/050657 WO2014020610A1 (en) 2012-08-02 2013-08-01 Compositions and methods for the treatment of bone voids and open fractures

Publications (2)

Publication Number Publication Date
EA201590049A1 true EA201590049A1 (ru) 2015-08-31
EA027543B1 EA027543B1 (ru) 2017-08-31

Family

ID=50027362

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201590049A EA027543B1 (ru) 2012-08-02 2013-08-01 Композиции и способы для лечения участков отсутствующей костной ткани и открытых переломов

Country Status (19)

Country Link
US (1) US9173976B2 (ru)
EP (1) EP2879620B1 (ru)
JP (1) JP6182213B2 (ru)
KR (1) KR101883807B1 (ru)
CN (1) CN104519834B (ru)
AU (1) AU2013298102B2 (ru)
BR (1) BR112015001843B1 (ru)
CA (1) CA2880130C (ru)
EA (1) EA027543B1 (ru)
ES (1) ES2802025T3 (ru)
HK (1) HK1204545A1 (ru)
IL (1) IL236823A0 (ru)
IN (1) IN2015DN01553A (ru)
MX (1) MX366048B (ru)
NZ (1) NZ704066A (ru)
PH (1) PH12015500226A1 (ru)
SG (1) SG11201500403RA (ru)
WO (1) WO2014020610A1 (ru)
ZA (1) ZA201500559B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10758639B2 (en) * 2014-10-02 2020-09-01 Polypid Ltd. Methods for the treatment of peri-implantitis
SG11201702469TA (en) 2014-10-02 2017-04-27 Polypid Ltd Compositions and methods for the treatment and prophylaxis of surgical site infections
US10485902B2 (en) 2015-08-28 2019-11-26 Thomas Jefferson University Antibiotic drug release sheath
US10029031B2 (en) * 2015-10-28 2018-07-24 Warsaw Orthopedic, Inc. Bone void filler having sustained therapeutic agent release
FR3064482B1 (fr) * 2017-04-03 2020-11-13 Horus Pharma Composition topique de doxycycline
FR3071729A1 (fr) * 2017-10-04 2019-04-05 Cementic Ciments dentaires desinfectants comprenant des liposomes
WO2020163425A1 (en) * 2019-02-05 2020-08-13 Flightpath Biosciences, Inc. Azlocillin and disulfiram-based formulations and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU752225B2 (en) * 1998-07-17 2002-09-12 Pacira Pharmaceuticals, Inc. Biodegradable compositions for the controlled release of encapsulated substances
EP2217260B1 (en) * 2007-12-04 2016-11-09 Ben-Gurion University Of The Negev Research And Development Authority Amphiphilic peptide matrices for treatment of osteoporosis
CA2730340C (en) * 2008-07-14 2017-02-07 Polypid Ltd. Sustained-release drug carrier composition
ES2732149T3 (es) * 2009-07-14 2019-11-20 Polypid Ltd Composición de vehículos de fármacos de liberación mantenida

Also Published As

Publication number Publication date
ES2802025T3 (es) 2021-01-15
US9173976B2 (en) 2015-11-03
PH12015500226B1 (en) 2015-04-06
CN104519834B (zh) 2016-10-12
MX2015001365A (es) 2015-09-07
IN2015DN01553A (ru) 2015-07-03
IL236823A0 (en) 2015-03-31
WO2014020610A1 (en) 2014-02-06
EA027543B1 (ru) 2017-08-31
CA2880130A1 (en) 2014-02-06
CA2880130C (en) 2019-09-24
BR112015001843B1 (pt) 2021-05-11
EP2879620B1 (en) 2020-04-22
MX366048B (es) 2019-06-26
KR20150038488A (ko) 2015-04-08
BR112015001843A2 (pt) 2017-07-04
NZ704066A (en) 2017-06-30
JP6182213B2 (ja) 2017-08-16
AU2013298102B2 (en) 2017-09-07
KR101883807B1 (ko) 2018-07-31
HK1204545A1 (en) 2015-11-27
EP2879620A1 (en) 2015-06-10
CN104519834A (zh) 2015-04-15
JP2015527131A (ja) 2015-09-17
EP2879620A4 (en) 2016-04-13
AU2013298102A1 (en) 2015-02-12
SG11201500403RA (en) 2015-02-27
PH12015500226A1 (en) 2015-04-06
ZA201500559B (en) 2016-12-21
US20150202349A1 (en) 2015-07-23

Similar Documents

Publication Publication Date Title
EA201590049A1 (ru) Композиции и способы для лечения участков отсутствующей костной ткани и открытых переломов
MX2015015772A (es) Implante quirurgico que comprende una capa que tiene aberturas.
ECSP10010372A (es) Métodos y composiciones que utilizan polipéptidos de fusión de klotho-fgf
MX344786B (es) Composiciones y metodos para tratar enfermedad de gaucher.
CR11731A (es) Composiciones y procedimientos para su preparación y uso
EP2608778A4 (en) COMPOSITIONS AND METHODS FOR TREATING BONE ANOMALIES
MX2014010455A (es) Metodos y composiciones para tratar enfermedad de huntington.
BR112013019083A2 (pt) combinação de (a) um imunoconjugado, composição farmacêutica, uso de (a) um imunoconjugado, método de tratamento de uma doença em um individuo, método de estímulo de função celular efetora em um indivíduo e kit destinado ao tratamento de uma doença.
AR090465A1 (es) Formas solidas de un profarmaco de nucleotidos de tiofosforamidato
CL2008000899A1 (es) Compuestos derivados de 3-imidazolil-indolilo, inhibidores de la interaccion entre p53 y mdm2 y/o mdm4; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento y/o profilaxis de enfermedades proliferativas.
UY32728A (es) Composición farmacéutica y procedimiento de tratamiento para la anticoncepción de emergencia
HRP20190222T1 (hr) Pripravak za popravljanje hrskavičnog tkiva, postupak njegove priprave i njegova upotreba
BRPI0917017B8 (pt) inibidores de pirrol de s-nitrosoglutationa redutase como agentes terapêuticos
BR112014023937A2 (pt) composição farmacêutica, agente farmacêutico de combinação e método de tratamento
MX346450B (es) Composiciones y métodos para el tratamiento de la enfermedad celíaca.
BR112013006938A2 (pt) kits, componentes e métodos para reconstrução de tecido
MX2016004556A (es) Composicion de hueso comprimido y metodo para usar la misma.
HK1216085A1 (zh) 形成水泥的組合物、三斜磷鈣石水泥、植入物及用於矯正骨缺損的方法
MX362405B (es) Composiciones y metodos para procedimientos de fusion de espina.
UY34070A (es) Método y composición para tratamiento de semillas.
UY34166A (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib
EP3041485A4 (en) Cell-seeded compositions and methods useful for treating bone regions
BR112013021035A2 (pt) composições e métodos de reposição de tecido macio aperfeiçoados
EA201200028A1 (ru) Альфа-1 мультимеры hla-g и их фармацевтическое применение
SG194235A1 (en) Methods of predicting the development of complement-mediated disease

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM